Semglee is a medicine used to treat diabetes in patients from 2 years of age. It contains the active substance insulin glargine. Semglee is a ‘biosimilar medicine’. This means that Semglee is highly similar to another biological medicine (the ‘reference medicine’) that is already authorised in the EU.
Therapeutic Indication
### Therapeutic indication Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
Therapeutic Area (MeSH)
N/AATC Code
A10AE04
ATC Item
insulin glargine
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| insulin glargine | N/A | 甘精胰岛素 |
EMA Name
Semglee
Medicine Name
Semglee
Aliases
N/ANo risk management plan link.
